Shelter Pharma Limited approved the conversion of 2,79,000 warrants into 1,14,000 equity shares at its Board Meeting on May 01, 2026. The company received ₹0.36 Crore as the remaining 75% exercise price from three non-promoter investors. This conversion increases the company's paid-up equity share capital to ₹16.73 Crore.
Shelter Pharma Limited has received an international purchase order worth USD 103,950 (approx. ₹0.98 Crore) from Taha Drugs & Chemicals Co. Ltd. for 189,000 boxes of 'All Vitamins' tablets. This order marks a significant milestone in the company's global expansion and revenue growth journey.
Value
₹0.98 Cr
Execution
Mutually agreed timelines as per purchase order and shipment schedule
Shelter Pharma Limited secured an international order worth $1,44,000 (₹1.35 Crore) from Sudan-based Taha Drugs & Chemicals Co. Ltd. The contract involves supplying Joemega Capsules and All Vitamins tablets within two months. This noteworthy export order enhances the company's international footprint in the nutraceutical market.
Shelter Pharma Ltd has commenced product exports to Sudan, including its daily multivitamin 'Allvitamin'. This move is part of the company's regular international supply operations to African markets, aimed at strengthening its global presence and diversifying revenue streams through consistent international supply relationships.
Shelter Pharma Limited has appointed key senior management personnel, including Mr. Javed as Zonal Sales Manager and Mr. Ashok Chauhan as Regional Sales Manager. These appointments aim to strengthen the sales and export structure to support business expansion and international growth. No financial considerations were disclosed in the announcement.
Shelter Pharma Limited informed the exchange that the Annual Secretarial Compliance Report under Regulation 24A is not applicable to the company. As an entity listed on the BSE SME platform, it is exempt from certain SEBI LODR provisions. This is a routine regulatory clarification for investors.
